PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $533.10 | 0.0% | -0.4% | +12.4% | -8.5% | +21.3% | +188.2% | +565.4% | |
| TTM Revenue | $1.28B | +13.4% | – | +13.4% | – | +149.0% | +100.0% | +100.0% | |
| TTM EPS | -$12.88 | -0.7% | – | -0.7% | – | -0.3% | +30.9% | +11.8% | |
| 23.52 | 0.0% | -0.4% | +16.9% | +6.6% | +67.6% | -28.7% | +379.0% | ||
| 9.59 | 0.0% | -0.4% | -0.7% | -30.9% | -49.4% | – | – | ||
| $11.83B | 0.0% | -0.4% | +13.0% | -6.6% | +30.1% | +267.7% | +1074.2% | ||
| -36.83 | 0.0% | +0.4% | -9.8% | +13.1% | -25.0% | -277.7% | -750.6% | ||
| Market Cap | $12B | 0.0% | -0.4% | +12.6% | -7.4% | +26.1% | +260.7% | +826.1% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 3.62 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 0.92 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 2.17 | - |
Formula
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl
